Aktienanalyse zu Veeva Systems Inc (VEEV)VEEVVeeva Systems Inc

Veeva Systems Inc. provides cloud solutions for the global life sciences industry. The Company offers cloud software, artificial intelligence (AI), data, and business consulting and is designed to meet the needs of its customers and their strategic business functions, from research and development through commercialization. Its product categories include Veeva Development Cloud, Veeva Quality Cloud, Veeva Commercial Cloud and Veeva Data Cloud. Veeva Development Cloud includes application suites for the clinical, regulatory, and safety functions of life sciences companies, all built on its Veeva Vault platform. Veeva Quality Cloud unifies applications, processes and partners across content management, training, quality management, assurance and control lab solutions on the Veeva Vault platform. Veeva Commercial Cloud comprises software and analytics solutions. It owns Ostro, a brand engagement platform for life sciences. It also provides Veeva Falcon MLR, an agentic MLR solution. It operates in the Healthcare sector (SERVICES-PREPACKAGED SOFTWARE industry).

Veeva Systems Inc is a good buy right now due to its strong revenue growth and positive analyst sentiment. The current price is $310.36, with a forward P/E of 30.21, indicating reasonable valuation for growth. The gross margin stands at 75.00%, showcasing robust profitability. However, the RSI is at 75.29, suggesting it may be overbought in the short term, which is a risk to consider.

14 analysts cover VEEV: 8 rate it Buy, 6 Hold and 0 Sell. The average price target is 317.10.